Angiotensin II AT2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats

Saavedra, 1992, Brain and pituitary angiotensin, Endocr. Rev., 13, 329, 10.1210/edrv-13-2-329

Bumpus, 1991, Nomenclature for angiotensin receptors. A report of the nomenclature committee of the council for high blood pressure research, Hypertension, 17, 720, 10.1161/01.HYP.17.5.720

Smith, 1992, Pharmacology of nonpeptide angiotensin II receptor antagonists, Annu. Rev. Pharmacol. Toxicol., 329, 135, 10.1146/annurev.pa.32.040192.001031

Tsutsumi, 1991, Characterization of AT2 angiotensin II receptors in rat anterior cerebral arteries, Am. J. Physiol., 261, H667

Strömberg, 1992, Angiotensin AT2 receptors regulate cerebral blood flow in rats, Neuroreport, 3, 703, 10.1097/00001756-199208000-00013

Strömberg, 1993, Nonpeptide angiotensin AT1 and AT2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats, J. Cereb. Blood Flow Metab., 13, 298, 10.1038/jcbfm.1993.37

Näveri, 1994, Angiotensin II AT2 receptor stimulation extends the upper limit of cerebral blood flow autoregulation: agonist effects of CGP 42112 and PD 123319, J. Cereb. Blood Flow Metab., 14, 38, 10.1038/jcbfm.1994.6

Dzau, 1988, Vascular renin-angiotensin system in hypertension, Am. J. Med., 84, 4, 10.1016/0002-9343(88)90463-9

Miyazaki, 1984, Vascular angiotensin-converting enzyme activity in man and other species, Clin. Sci., 66, 39, 10.1042/cs0660039

Paulson, 1988, Role of angiotensin in autoregulation of cerebral blood flow, Circulation, 77, I55

Dirnagl, 1989, Continuous measurement of cerebral cortical blood flow by laser-doppler flowmetry in a rat stroke model, J. Cereb. Blood Flow Metab., 9, 589, 10.1038/jcbfm.1989.84

Haberl, 1989, Laser-doppler assessment of brain microcirculation: effect of systemic alterations, Am. J. Physiol., 256, H1247

Wilkinson, 1990

Wei, 1978, Vasoconstrictor effect of angiotensin on pial arteries, Stroke, 9, 487, 10.1161/01.STR.9.5.487

Joyner, 1988, In vivo microscopy of the cerebral microcirculation using neonatal allografts in hamsters, Circ. Res., 63, 758, 10.1161/01.RES.63.4.758

Mayhan, 1988, Responses of cerebral arteries after ischemia and reperfusion in cats, Am. J. Physiol., 255, H879

Manabe, 1989, Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery, J. Pharmacol. Exp. Ther., 251, 317

Toda, 1990, Modifications by endogenous prostaglandins of angiotensin II-induced contractions in dog and monkey cerebral and mesenteric arteries, J. Pharmacol. Exp. Ther., 252, 374

Whalley, 1987, Analysis of the mechanism of action of bradykinin on human basilar artery in vitro, Naunyn-Schmiedeberg's Arch. Pharmacol., 335, 433, 10.1007/BF00165559

Barry, 1984, Cerebrovascular aspects of converting-enzyme inhibition I: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats, J. Hypertens., 2, 589, 10.1097/00004872-198412000-00003

Waldemar, 1989, Angiotensin converting enzyme inhibition and the upper limit of cerebral blood flow autoregulation: Effect of sympathetic stimulation, Circ. Res., 64, 1197, 10.1161/01.RES.64.6.1197

Kang, 1992, Modulation of net outward current in cultured neurons by angiotensin II: involvement of AT1 and AT2 receptors, Brain Res., 580, 317, 10.1016/0006-8993(92)90960-H

Brechler, 1993, Agonistic and antagonistic properties of angiotensin analogs at the AT2 receptor in PC12W cells, Regul. Pept., 44, 207, 10.1016/0167-0115(93)90244-3

Widdop, 1993, Central administration of PD 123319 or EXP-3174 inhibits effects of angiotensin II, Am. J. Physiol., 264, H117

Takahasi, 1994, Protein tyrosine phosphatase inhibition by angiotensin II in rat pheocromocytoma cells through type 2 receptor, AT2, Biochem. Biophys. Res. Commun., 198, 60, 10.1006/bbrc.1994.1009

Hoyer, 1993, Partial agonists, full agonists, antagonists: dilemmas of definition, Trends Pharmacol. Sci., 14, 270, 10.1016/0165-6147(93)90129-8

Wong, 1992, Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD 123177 in rats, Eur. J. Pharmacol., 220, 267, 10.1016/0014-2999(92)90758-V

Dudley, 1990, Subclasses of angiotensin II binding sites and their functional significance, Mol. Pharmacol., 38, 370

Wong, 1990, Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2), J. Pharmacol. Exp. Ther., 255, 584

Bui, 1992, Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier, Eur. J. Pharmacol., 219, 147, 10.1016/0014-2999(92)90593-S

Jarden, 1984, Cerebrovascular aspects of converting-enzyme inhibition II: Blood-brain barrier permeability and effect of intracerebroventricular administration of captopril, J. Hypertens., 2, 599, 10.1097/00004872-198412000-00004

Haberl, 1990, Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles, Am. J. Physiol., 258, H1840

Haberl, 1991, Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles, Circ. Res., 68, 1621, 10.1161/01.RES.68.6.1621

Swanson, 1992, Discovery of a distinct binding site for angiotensin II(3–8), a putative angiotensin IV receptor, Regul. Pept., 40, 409, 10.1016/0167-0115(92)90527-2

Faraci, 1990, Regulation of large cerebral arteries and cerebral microvascular pressure, Circ. Res., 66, 8, 10.1161/01.RES.66.1.8

Haas, 1983, Death from cerebral hypoperfusion during nitroprusside treatment of acute angiotensin-dependent hypertension, Am. J. Med., 75, 1071, 10.1016/0002-9343(83)90891-4

Haas, 1985, Role of angiotensin in lethal cerebral hypoperfusion during treatment of acute hypertension, Arch. Intern. Med., 145, 1922, 10.1001/archinte.145.10.1922

Brown, 1986, Does angiotensin-II protect against strokes?, Lancet, 2, 427, 10.1016/S0140-6736(86)92136-7